Prolonged inhibition of O6-methylguanine DNA methyltransferase in human tumor cells by O6-benzylguanine in vitro and in vivo

Journal of Pharmacology and Experimental Therapeutics

Volumn 291, Issue 3, 1999, Pages 1269-1275

  Kreklau, Emiko L ^a   Kurpad, Chandrika ^a   Williams, David A ^b   Erickson, Leonard C ^a  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

6 O BENZYLGUANINE; CARMUSTINE; METHYLATED DNA PROTEIN CYSTEINE METHYLTRANSFERASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CELL KILLING; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INHIBITION; HUMAN; HUMAN CELL; INTRAPERITONEAL DRUG ADMINISTRATION; NONHUMAN; PRIORITY JOURNAL; TUMOR CELL; XENOGRAFT;

ANIMALS; ANTINEOPLASTIC AGENTS, ALKYLATING; BRAIN NEOPLASMS; CARMUSTINE; ENZYME INHIBITORS; FEMALE; GLIOMA; GUANINE; HUMANS; MALE; MICE; MICE, INBRED NOD; MICE, SCID; NEOPLASM TRANSPLANTATION; O(6)-METHYLGUANINE-DNA METHYLTRANSFERASE; TUMOR CELLS, CULTURED;

EID: 0032749140     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Allay JA, Dumenco LL, Koc O, Liu L and Gerson SL (1995) Retroviral transduction and expression of the human alkyltransferase cDNA provides nitrosourea resistance to hematopoietic cells. Blood 85:3342-3351.
2. 6-alkylguanine DNA alkyltransferase correlates with potentiation of temozolomide and CCNU toxicity in human tumor cells. Br J Cancer 67:1299-1302.
3. Berger NA (1993) Alkylating agents, in Cancer: Principles and Practice of Oncology (DeVita VT, Hellman S and Rosenberg SA) pp 400-409, JB Lippincott Company, Philadelphia.
4. 6-alkylguanine-DNA alkyltransferase and BCNU treated defined length synthetic oligonucleotides. Nucleic Acids Res 16:6779-6788.
5. 6-alkylguanine DNA alkyltransferase activity in mammalian tissues and human tumor xenografts in nude mice by treatment with 06-methylguanine. Cancer Chemother Pharmacol 25:103-108.
6. 6-benzylguanine anaogues on sensitivity of human tumor cells to the cytotoxic effects of alkylating agents. Cancer Res 51:3367-3372.
7. 6-benzylguanine provides a means to evaluate the role of this protein in protection against carcinogenic and therapeutic alkylating agents. Proc Natl Acad Sci USA 87:5368-5372.
8. 6-benzylguanine analogs on the sensitivity of human colon xenografts to BCNU. Biochem Pharmacol 46:285-290.
9. 6-methylguanine on DNA interstrand cross-link formation by chloroethylnitrosoureas and 2-chloroethyl(methylsulfonyl)-methanesulfonate. Cancer Res 48:3603-3606.
10. 6-benzylguanine and its effect on sensitivity of a human glioma to a 1-(2-chloroethyl)-3-(4-methylcyclohexyl)-1-nitrosourea. Cancer Commun 2:371-377.
11. 6-alkylguanine pretreatment on the sensitivity of human colon tumor cells to the cytotoxic effects of chloroethylating agents. Cancer Res 48:4500-4504.
12. 6-benzylguanine and 1,3-bis(2-chloroethyl)-1-nitrosourea. Cancer Chemother Pharmacol 32:471-476.
13. Friedman HS, Dolan ME, Moschel RC, Pegg AE, Felker GM, Rich J, Bigner DD and Schold C (1992) Enhancement of nitrosourea activity in medulloblastoma and glioblastoma multiforme. J Natl Cancer Inst 84:1926-1931.
14. 6-benzylguanine for patients undergoing surgery for malignant glioma. J Clin Oncol 16:3570-3575.
15. Futscher BW, Micetich KC, Barnes DM, Fisher RI and Erickson LC (1989) Inhibition of specific DNA repair system and nitrosourea cytotoxicity in resistant human cancer cells. Cancer Commun 1:165-73.
16. Gerard B, Aandal S, Lee SM, Leyvraz S, Lucas C, D'Incalci M and Bizzari JP (1993) Activity and unexpected lung toxicity of the sequential administration of two alkylating agents-dacarbazine and fotemustine - in patients with melanoma. Eur J Cancer 29:711-719.
17. 6-alkylguanine-DNA alkyltransferase by streptozotocin in vivo. Cancer Res 49:3134-3138.
18. 6-alkylguanine DNA alkyltransferase. Cancer Res 48:1521-1527.
19. 6-benzylguanine on the sensitivity of human colon tumor xenografts to 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU). Biochem Pharmacol 46:285-290.
20. 6-methylguanine-DNA methyltransferase and chloroethyl-nitrosourea-treated DNA. Cancer Res 52:6052-6058.
21. 6-alkylguanine-DNA alkyltransferase. Blood 87:1957-1961.
22. Kohn KW (1977) Interstrand cross-linking of DNA by 1,3-bis(2-chloroethyl)-1-nitrosourea and other 1-(2-haloethyl)-1-nitrosoureas. Cancer Res 37:1450-1454.
23. 6-methylguanine DNA methyltransferase (MGMT) expression in Mer+ human tumor cells. Carcinogenesis 16:2255-2257.
24. 6-benzylguanine enables the specific therapy of nitrosourea-resistant intracranial human glioma xenografts in athymic rats with 1,3-bis(2-chloroethyl)-1-nitrosourea. Cancer Chemother Pharmacol 39:307-316.
25. Lemoine A, Lucas C and Ings RM (1991) Metabolism of the chloroethylnitrosoureas. Xenobiotica 21:775-791.
26. 6-benzylguanine and sensitization to BCNU. Cancer Chemother Pharmacol 35:262-266.
27. 6-benzylguanine (BG), streptozotocin (STZ), and 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU), in vitro and in vivo. Biochem Pharmacol 48: 2127-2134.
28. Maze R, Carney JP, Kelley MR, Glassner DA, Williams L and Samson L (1996) Increasing DNA repair methyltransferase levels via bone marrow stem cell transduction rescues mice from the toxic effects of 1,3-bis(2-chloroethyl)-1 nitrosourea, a chemotherapeutic alkylating agent. Proc Natl Acad Sci USA 93:206-210.
29. 6-methylguanine DNA methyltransferase complementary DNA. J Imnunol 158:1006-1013.
30. Micetich KC, Futscher B, Koch D, Fisher RI and Erickson LC (1992) Phase I study of streptozotocin- and carmustine-sequenced administration in patients with advanced cancer. J Natl Cancer Inst 84:256-260.
31. 6-benzylguanine on the sensitivity of human tumor xenografts to 1,3-bis(2-chloroethyl)-nitrososurea and on DNA interstrand cross-link formation. Cancer Res 52:1171-1175.
32. 6-alkylguanine-DNA alkyltransferase: Regulation and importance in response to alkylating carcinogenic and therapeutic agents. Cancer Res 50:6119-6129.
33. 6-benzylguanine plus BCNU. Cancer Res 57:4817-4823.
34. 6-methylguanine-DNA methyltransferase. Nucleic Acids Res 11:7743-7758.
35. 6-alkylguanine-DNA-alkyltransferase. Clin Cancer Res 2:1129-1134.
36. 6-Benzylguanine: A clinical trial establishing the biochemical modulatory dose in tumor tissue for alkyltransferase-directed DNA repair. Cancer Res 59:2402-2410.
37. 1-deoxyguanasyl] ethane in DNA treated with N,N′-bis(2-chloroethyl)-N-nitrosourea. Cancer Res 42:3102-3105.
38. 6-alkylguanine DNA alkyltransferase activity to temozolomide and BCNU. Br J Cancer 73:1049-1052.
39. 6-benzylguanine/temozolomide combination: An evaluation in a human melanoma xenograft model. Cancer Chemother Pharmacol 40:266-272.
40. 6-alkylguanine-DNA alkyltransferase-directed DNA repair in metastatic colon cancers. J Clin Oncol 13:2301-2308.